Breaking News

Ranbaxy to Deploy Instem’s Preclinical Software

May 9, 2014

Will automate lab processes at R&D headquarters in India

Ranbaxy Laboratories has purchased Instem’s Provantis preclinical software suite to automate lab processes at its R&D headquarters in Gurgaon, India. Provantis modules to be deployed include Inlife, Pathology, Tables & Statistics, Clinical Pathology, Protocol & Report Assembly, which will replace in-house developed applications. 
 
Neil Donaldson, Instem’s vice president of global sales, Europe & Asia, said, “We are delighted to welcome Ranbaxy as our newest client in the Asia Pacific region and look forward to a long and successful partnership. Instem recognizes the increasingly important role that Indian organizations play in the global pharmaceutical market and we are committed to supporting the future growth and development of the Indian R&D community.”

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity